Skip to search formSkip to main contentSkip to account menu

S 1006

Known as: S-1006 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cephalosporins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
El valor de la radiografía de tórax: lo que nos enseña. 3. Hueso.
Poster: "SERAM 2012 / S-1006 / El valor de la radiografia de torax: lo que nos ensena. 3. Hueso." by: "C. Gomez Rebollo, V… 
1994
1994
Effect of membrane surface potential on the uptake of anionic compounds by liposomes.
1994
1994
Changes in the permeation rate of organic anions through the intestinal brush-border membrane with membrane surface potential.
1993
1993
[Pharmacokinetic and clinical studies of S-1108 in the pediatric field].
Pharmacokinetic and clinical studies on S-1108, a new oral cephem antibiotic, were performed in the field pediatrics. The… 
1993
1993
[Clinical pharmacology and efficacy of S-1108].
We studied the pharmacokinetics of a new cephem antibiotic, S-1108, in patients with impaired kidney functions. Serum and urinary… 
1993
1993
[Influence of S-1108 on intestinal bacterial flora].
The effect of S-1108, a new oral cephem antibiotic, on intestinal bacterial flora was studied in tetra-contaminated mice and… 
1993
1993
[Clinical studies on S-1108 in the field pediatrics].
Clinical studies on S-1108, a new oral cephem antibiotic, were carried out in the field of pediatrics. The following results were… 
1993
1993
[Laboratory and clinical studies on S-1108 in the pediatric field].
Laboratory and Clinical Studies on S-1108, a new oral cephem antibiotic, were carried out to evaluate its usefulness at a dose… 
1992
1992
Phase I clinical studies of S-1108: safety and pharmacokinetics in a multiple-administration study with special emphasis on the influence on carnitine body stores
S-1108, the prodrug of S-1006, was given to healthy volunteers three times a day (TID) for 8 days in a dose of 200 mg in a… 
1992
1992
In vitro activity and susceptibility to hydrolysis of S-1006
The in vitro activity of S-1006, the active component of a new orally absorbed cephalosporin, S-1108, inhibited 90% of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)